Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
暂无分享,去创建一个
R. Derynck | M. Yamauchi | D. Gibbons | H. Chapman | Ying-Ying Wei | J. Peters | B. J. Backes | C. L. Le Saux | Thomas J. Kim | D. Peng | Dana Duan | Julia R Jackson | C. Calhoun | Ying‐Ying Wei | Cheresa Calhoun
[1] K. J. Grande-Allen,et al. ZEB1 Induces LOXL2-Mediated Collagen Stabilization and Deposition in the Extracellular Matrix to Drive Lung Cancer Invasion and Metastasis , 2016, Oncogene.
[2] H. Collard,et al. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. , 2017, The Lancet. Respiratory medicine.
[3] V. Weaver,et al. Force-dependent breaching of the basement membrane. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[4] Ja Hyun Koo,et al. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt , 2016, Nature Communications.
[5] S. Paiva,et al. Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction. , 2016, International journal of cardiology.
[6] S. Hanash,et al. Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space* , 2016, The Journal of Biological Chemistry.
[7] Shiwei Liu,et al. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men , 2016, European Journal of Epidemiology.
[8] B. Pasche,et al. TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis. , 2016, Cancer research.
[9] B. Péter,et al. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials , 2016, European Biophysics Journal.
[10] S. Estrem,et al. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway , 2015, Drug design, development and therapy.
[11] G. Sudhandiran,et al. Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF‐β1 signalling , 2015, Clinical and experimental pharmacology & physiology.
[12] Jérôme Cros,et al. Targeting the TGFβ pathway for cancer therapy. , 2015, Pharmacology & therapeutics.
[13] J. Berzofsky,et al. Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008) , 2015, Cancer Immunology, Immunotherapy.
[14] A. Gaggar,et al. Fibrosis: ultimate and proximate causes. , 2014, The Journal of clinical investigation.
[15] Hong-Mei Zhang,et al. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid , 2014, Cancer biology & medicine.
[16] Zheng Wang,et al. Corilagin Attenuates Aerosol Bleomycin-Induced Experimental Lung Injury , 2014, International journal of molecular sciences.
[17] Dean Sheppard,et al. TGF-β activation and function in immunity. , 2014, Annual review of immunology.
[18] T. Ronnebaum,et al. Human copper-dependent amine oxidases. , 2014, Archives of biochemistry and biophysics.
[19] H. Collard,et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. , 2014, American journal of respiratory and critical care medicine.
[20] H. Chapman,et al. Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline. , 2013, American journal of respiratory cell and molecular biology.
[21] D. Griggs,et al. Selective αv integrin depletion identifies a core, targetable molecular pathway that regulates fibrosis across solid organs , 2013, Nature Network Boston.
[22] E. D. Bal de Kier Joffé,et al. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer , 2013, Clinical & Experimental Metastasis.
[23] Thomas R Cox,et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. , 2013, Cancer research.
[24] S. Friedman,et al. Therapy for Fibrotic Diseases: Nearing the Starting Line , 2013, Science Translational Medicine.
[25] Oliver Eickelberg,et al. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. , 2012, Proceedings of the American Thoracic Society.
[26] A. Hata,et al. Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.
[27] M. Yamauchi,et al. Lysine post-translational modifications of collagen. , 2012, Essays in biochemistry.
[28] M. Anderton,et al. Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors , 2011, Toxicologic pathology.
[29] D. Mereles,et al. Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises? , 2011, International journal of molecular sciences.
[30] Arnoud Sonnenberg,et al. Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice. , 2011, The Journal of clinical investigation.
[31] Anirudh Sethi,et al. Transforming Growth Factor– Induces Extracellular Matrix Protein Cross-Linking Lysyl Oxidase (LOX) Genes in Human Trabecular Meshwork Cells , 2011 .
[32] M. Kennett,et al. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. , 2010, Carcinogenesis.
[33] Mikala Egeblad,et al. Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.
[34] M. Raghunath,et al. Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis _ state of the art , 2009, Fibrogenesis & tissue repair.
[35] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[36] M. Raghunath,et al. The Scar‐in‐a‐Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well , 2009, British journal of pharmacology.
[37] A. Bandyopadhyay,et al. Defining the Role of Integrin αvβ6 in Cancer , 2009 .
[38] F. Martinez,et al. NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.
[39] A. Bandyopadhyay,et al. Defining the role of integrin alphavbeta6 in cancer. , 2009, Current drug targets.
[40] J. Mehta,et al. Regulation of TGFβ1-mediated Collagen Formation by LOX-1 , 2008, Journal of Biological Chemistry.
[41] M. Yamauchi,et al. Lysine hydroxylation and cross-linking of collagen. , 2008, Methods in molecular biology.
[42] S. Mertens-Talcott,et al. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. , 2006, Journal of agricultural and food chemistry.
[43] David Heber,et al. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. , 2006, The Journal of nutrition.
[44] Shinichi Kuriyama,et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. , 2006, JAMA.
[45] D. Ferreira,et al. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. , 2006, Phytochemistry.
[46] D. Sheppard,et al. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. , 2006, Proceedings of the American Thoracic Society.
[47] Quynh-Thu Le,et al. Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.
[48] D. Sheppard,et al. Transforming Growth Factor A Central Modulator of Pulmonary and Airway Inflammation and Fibrosis , 2006 .
[49] K. Csiszȧr,et al. A molecular role for lysyl oxidase‐like 2 enzyme in Snail regulation and tumor progression , 2005, The EMBO journal.
[50] R. Sormunen,et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. , 2005, The American journal of pathology.
[51] B. Casto,et al. Pharmacokinetics of Anthocyanins and Ellagic Acid in Healthy Volunteers Fed Freeze‐Dried Black Raspberries Daily for 7 Days , 2005, Journal of clinical pharmacology.
[52] Dean Sheppard,et al. Integrin-mediated activation of latent transforming growth factor β , 2005, Cancer and Metastasis Reviews.
[53] Jonathan M. Yingling,et al. Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.
[54] C. Speer,et al. The Role of Transforming Growth Factor β in Lung Development and Disease , 2004 .
[55] Jiangang Gao,et al. Elastic fiber homeostasis requires lysyl oxidase–like 1 protein , 2004, Nature Genetics.
[56] J. Yingling,et al. Development of TGF-beta signalling inhibitors for cancer therapy. , 2004, Nature reviews. Drug discovery.
[57] C. Speer,et al. The role of transforming growth factor beta in lung development and disease. , 2004, Chest.
[58] S. Birge,et al. Lysyl Oxidase Is Required for Vascular and Diaphragmatic Development in Mice* , 2003, The Journal of Biological Chemistry.
[59] K. Kivirikko,et al. Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice , 2002, Circulation.
[60] Sandra N. Mohr,et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[61] David G. Morris,et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[63] P. Trackman,et al. Properties and function of lysyl oxidase. , 1991, American journal of respiratory cell and molecular biology.